Neonatal Thyroid-Stimulating Hormone Screening as a Monitoring Tool for Iodine Deficiency in Turkey

Nilgün Çaylan1, Başak Tezel, Sema Özbaş

  • 1Public Health Institution of Turkey, Department of Child and Adolescent Health, Ankara, Turkey Phone: +90 312 565 60 76

Insights

Neonatal screening indicates mild iodine deficiency in Turkey, with elevated thyroid-stimulating hormone (TSH) levels observed in 7.2% of newborns. Further nationwide studies are recommended to confirm iodine status.

Area of Science:

  • Endocrinology
  • Public Health
  • Pediatrics

Background:

  • Thyroid-stimulating hormone (TSH) levels in newborns serve as a key indicator for assessing population-level iodine deficiency (ID) and monitoring iodine supplementation programs.
  • The National Newborn Screening Program (NNSP) for congenital hypothyroidism (CH) collects crucial data for public health surveillance.

Purpose of the Study:

  • To analyze neonatal TSH levels from the 2014 NNSP data to predict the current iodine nutrition status in Turkey.
  • To identify regional and seasonal variations in elevated TSH levels as indicators of potential iodine deficiency.

Main Methods:

  • Utilized heel-prick blood samples from newborns collected on filter paper cards, analyzing results from samples obtained >48 hours post-birth.
  • Assessed the severity of iodine deficiency using World Health Organization (WHO) epidemiologic criteria.
  • Classified elevated TSH levels (>5 mIU/L) based on province, region, birth season, and sampling time.

Main Results:

  • A total of 1,270,311 newborns' screening results were included in the analysis.
  • The national prevalence of elevated TSH was 7.2%.
  • Significant regional variations were observed, with the highest TSH elevation rate in Gaziantep (15.9%) and the lowest in Tekirdağ (4.0%). Seasonal analysis showed the highest prevalence in winter (7.4%).

Conclusions:

  • Neonatal CH screening results suggest that Turkey may be experiencing mild iodine deficiency.
  • Further nationwide studies are essential for a direct assessment and accurate monitoring of iodine status in vulnerable populations.
Abstract

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
8.8K
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
281
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
6.4K
Redox Titration: Iodimetry and Iodometry01:23

Redox Titration: Iodimetry and Iodometry

Iodometry and iodimetry are analytical methods used to determine the concentration of oxidizing or reducing agents using iodine. In iodometric titrations, the oxidizing analyte solution is usually acidified and treated with an excess of iodide ions, which generates an equivalent amount of iodine in equilibrium with triiodide. The released iodine is subsequently titrated directly against a standardized reducing agent. As the dilute iodine color becomes pale yellow, a few drops of freshly...
6.8K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
322
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
505